Intensity Therapeutics receives Nasdaq minimum bid price deficiency notice

INTENSITY THERAPEUTICS, INC.

Nasdaq notified INTS on June 6, 2025 that bid price was below $1.00 for 30 consecutive business days.
Company has a 180-day grace period, until December 3, 2025, to regain compliance.
Compliance can be achieved if closing bid price is $1.00 or more for 10 consecutive business days.
If not compliant by deadline, INTS may seek a second grace period or consider a reverse stock split.
No immediate effect on listing or trading; stock continues on Nasdaq Capital Market under symbol INTS.

item 3.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.